Contact this trialFirst, we need to learn more about you.
Atezolizumab for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 2
New York, New York
This trial was designed to see if the immunotherapy drug atezolizumab is safe and effective in treating Non-Small Cell Lung Cancer. The study gave atezolizumab to patients before and after surgery, and then monitored them for up to 3 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.